After a turbulent three days, Asian markets have found stability as stocks recover from steep declines. Measures from the Chinese government and positive comments from Treasury Secretary Bessent have helped restore investor confidence.
Tensions escalate as Trump threatens China with a 50% tariff unless it retracts its counter-tariff. The potential trade war sends global markets into turmoil, with significant impacts on US-China trade relations.
In a surprising turn of events, BlackRock's planned acquisition of strategic Panama ports has been delayed due to intervention from Chinese regulators. This unexpected hold raises questions about international trade dynamics and investor confidence.
Chinese authorities are probing CK Hutchison's sale of its overseas port businesses, following concerns over security and antitrust issues linked to its Panama operations divested under US pressure.
CK Hutchison's proposed $23 billion sale of port assets faces strong criticism from China, pressuring the family of billionaire Li Ka-shing to reconsider. Analysts suggest the deal could still proceed without Chinese approval.
China has vehemently criticized a Hong Kong conglomerate's planned $19 billion deal to sell ports, warning it would undermine its influence over vital shipping routes, particularly the Panama Canal.
In a monumental move, BYD has raised $5.59 billion through a primary share sale, marking the largest equity offering in Hong Kong for four years. The funds will boost its R&D and international expansion efforts, with a strategic partnership on the horizon.
Discover how Mixue Bingcheng transformed from a small ice cream shop to the world's largest food chain, overtaking McDonald's and Starbucks with its affordable offerings and massive expansion.
Mixue Ice Cream and Tea, a rising star in the bubble tea industry, has surpassed McDonald's and Starbucks in outlets. With a stunning 30% stock jump on its IPO, find out how this Chinese brand is making waves amidst economic challenges.
A new coronavirus discovered in bats has sent Asian diagnostic kit makers and vaccine producers’ stocks soaring. Researchers warn of potential animal-to-human transmission.
